Gapping down
In reaction to earnings/guidance:
- AOUT -19.1% (also announces $15 mln share repurchase program), MESA -18.2%, CHWY -9.1%, FIZZ -8.6%, MTN -5.4%, LULU -1.4%
Other news:
- EVBG -36.3% (CEO to resign; also reiterates Q4 guidance)
- ANGN -20.6% (reports topline results from Phase 2 GUARD Trial of ANG-3777)
- MRNA -10.4% (announces interim data from the Phase 1 study of the Company's quadrivalent seasonal flu vaccine candidate, mRNA-1010)
- OBSV -1.7% (reports 52-Week Data from the Phase 3 PRIMROSE studies of linzagolix for the treatment of uterine fibroids demonstrating sustained safety and efficacy results at 52 weeks to be presented orally)
- PTRA -1.6% (names new CEO)
- AZUL -1.6% (reports November 2021 traffic)
- FIGS -1.3% (CFO Jeffrey Lawrence decided to retire, effective December 24, 2021) TSLA -1.2% (Elon Musk tweets "thinking of quitting my jobs & becoming an influencer full-time wdyt")
Analyst comments:
- PTON -4.4% (downgraded to Neutral from Outperform at Credit Suisse)
- LUV -4% (downgraded to Sell from Neutral at Goldman)
- CURV -1.8% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- FIS -1.5% (downgraded to In-line from Outperform at Evercore ISI),